NEWS & EVENTS

Accrol Final results Webinar - Thursday 13th July, 5.30pm

The management of Accrol Group Holdings plc (AIM:ACRL), a leading independent tissue converter, manufacturing toilet rolls, kitchen rolls, facial tissues …

READ MORE

Benchmark Holdings results webinar - Thursday 29th June, 11:45am

The management of Benchmark Holdings (AIM:BMK), the aquaculture biotechnology and food chain sustainability business, would like to invite you to …

READ MORE

Watkin Jones results webinar - Monday 19th June, 2017

The management of Watkin Jones (AIM:WJG), one of the UK's leading construction and development companies, would like to invite you …

READ MORE
READ MORE NEWS & EVENTS

TWEETS

$GHT.L shares jump on excellent H1, have doubled in last year. Revs £9.9m +26%, adj EBITDA £2.2m + 46%. Clareti license sales up 100%< ...

$RBG.L better news in FY update: sales +9.2% (lfl +1.5%), 6 new bars that traded well. Results out 3 Oct, and seen in line with Board view.

$BXP.L 'delighted' to receive 4th approval from the US FDA for muscle relaxant Methocarbamol tablets. Launch in Q4, 2017, est. market $30m.

$AUG.L @Augeanplc H1 update: broadly in line, sees FY growth at low end of forecasts. Useful cost cuts, Radioactive and Industry both strong

Global markets were weak on Monday as UK / US growth expectations were cut by IMF , but UK stocks should recover a little at opening

$VAST.L conditional heads of terms for $10m external investment to drive growth plans, mostly in Romania. Would equate to 29% stake in VAST.

FOLLOW US ON TWITTER

WHY CHOOSE ED

"MHP believes commissioned research is an important part of the toolkit to attract new investors and improve liquidity. We rate ED's analysts and research very highly as one of the leading providers in this space."

Reg Hoare
MHP Communications

MORE REASONS

"The team at ED consistently produce high quality research and highlight profitable investment opportunities, an invaluable tool for small cap investors in this under researched space."

Simon Thompson
Investors Chronicle

MORE REASONS

"Thanks for working over the weekend on this – it is really appreciated, as always Benchmark gets massive benefit from ED’s work for us, and from your team’s wise counsel at these key moments."

Malcolm Pye
Benchmark Holdings

MORE REASONS

"There is a need now, more than ever before, for real insight and clarity to be brought to company messages for investors….I would strongly recommend Equity Development to the management of any company."

Christian Hobart
Small Cap Equity Salesman

MORE REASONS